¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, Á¦Ç°º°, ¸ðµåº°, ¾à¹°º°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens, Post-employment), By Product, By Mode, By Drug, By End-use (IT/Finance, Manufacturing), And Segment Forecasts, 2025 - 2033
»óǰÄÚµå : 1813930
¸®¼­Ä¡»ç : Grand View Research
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,431,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,848,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,683,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(ÀÚȸ»ç Æ÷ÇÔ)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÃÀå ±Ô¸ð¿Í µ¿Çâ:

¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå ±Ô¸ð´Â 2024³â 25¾ï 7,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2033³â¿¡´Â 40¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2033³â±îÁö CAGR 5.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ¾ö°ÝÇÑ ÀÛ¾÷Àå ¾ÈÀü ±ÔÁ¤, ¾à¹° ³²¿ë À§Çè¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼­ ¿¹¹æÀû ¼±º° Á¶Ä¡ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¾à¹° °Ë»ç ÇÁ·Î±×·¥Àº ºÒ¹ý ¹°ÁúÀÇ Á¸Àç¿Í 󹿾àÀÇ ¿À¿ëÀ» °¨ÁöÇϱâ À§ÇØ ±¤¹üÀ§ÇÏ°Ô ½ÃÇàµÇ°í ÀÖÀ¸¸ç, Á¾ÇÕÀûÀÎ °Ë»ç ÇÁ·ÎÅäÄÝÀº ¿¬¹æ ¹× ÁÖÁ¤ºÎ ¿ä°Ç Áؼö¸¦ Áö¿øÇÏ°í »ý»ê¼ºÀ» ÃËÁøÇϸç ÀÛ¾÷Àå »ç°í¸¦ ÁÙÀÔ´Ï´Ù.

Á÷Àå ³» ä¿ë Àü °Ë»ç ¹× ¹«ÀÛÀ§ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä´Â ½Å¼Ó °Ë»ç ŰƮ, ½ÇÇè½Ç ±â¹Ý °Ë»ç ¹× ±¸°­¾× °Ë»ç ¹æ¹ýÀÇ °³¼±¿¡ ÈûÀÔ¾î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ °á°ú ½Ã½ºÅÛ°ú ÀÚµ¿ º¸°í¸¦ ÅëÇØ ÇÁ·Î¼¼½º°¡ ´õ¿í ½Å¼ÓÇϰí Á¤È®ÇØÁ® °í¿ëÁÖ°¡ ½Å¼ÓÇÑ Ã¤¿ë °áÁ¤À» ³»¸®°í Á÷¿øÀ» º¸´Ù È¿°úÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠÁÖ¿¡¼­ ´ë¸¶ÃÊ ´Ü¼Ó¹ýÀÌ °³Á¤µÊ¿¡ µû¶ó ÁÖ¿ä ±â¾÷µéÀº ÄÄÇöóÀ̾𽺠¿ä±¸ »çÇ×°ú ÁøÈ­ÇÏ´Â ¹ýÀû ±âÁØÀ» ¸ðµÎ ÃæÁ·½Ã۱â À§ÇØ °Ë»ç Á¤Ã¥À» Á¶Á¤Çϰí ÀÖ½À´Ï´Ù.

2024³â ¹Ì±¹ Áßµ¶¼¾ÅͰ¡ ½Ç½ÃÇÑ Àü±¹ Á¶»ç¿¡ µû¸£¸é, ¹Ì±¹ ±Ù·ÎÀÚÀÇ 15.3%°¡ ¾ËÄÚ¿ÃÀÇ ¿µÇâÀ» ¹Þ¾Æ ÀÏÇÑ ÀûÀÌ ÀÖÀ¸¸ç, 2.9%´Â ºÒ¹ý ¾à¹°ÀÇ ¿µÇâÀ» ¹ÞÀº ÀûÀÌ ÀÖ´Ù°í ÀÎÁ¤Çß½À´Ï´Ù. ÀÌ´Â °í¿ëÁÖ°¡ Á÷¸éÇÑ Áö¼ÓÀûÀÎ µµÀü°úÁ¦¸¦ º¸¿©ÁÖ¸ç, Á÷ÀåÀÇ ¾ÈÀü°ú »ý»ê¼ºÀ» º¸È£Çϱâ À§ÇÑ °­·ÂÇÑ ¾à¹° °Ë»ç Á¤Ã¥ÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¾à¹° »ç¿ë Àå¾Ö(SUD)¸¦ °¡Áø Á÷¿øÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á÷Àå °Ë»çÀÇ Á߿伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ¾à¹° ³²¿ëÀº »ý»ê¼º ÀúÇÏ, °á±Ù Áõ°¡, Áúº´ ÀÌȯÀ² Áõ°¡·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ, Á÷¿øµéÀÇ »ç±â¸¦ ¶³¾î¶ß¸®°í »ê¾÷ÀçÇØ ¹× ºÎ»ó À§ÇèÀ» Áõ°¡½ÃÄÑ ¹Ì±¹ ±â¾÷µéÀº ¸Å³â ¼ö½Ê¾ï ´Þ·¯ÀÇ ¼Õ½ÇÀ» ÀÔ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ °í¿ëÁÖ ¹× Á÷Àå¿¡¼­ÀÇ ¾à¹° °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â ¾ÕÀ¸·Îµµ ¹Ì±¹ Àü¿ª¿¡¼­ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àü¹ÝÀûÀ¸·Î ¹Ì±¹ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀåÀº ½Å¼Ó¼º, Á¤È®¼º, »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇÑ ²ÙÁØÇÑ ±â¼ú Çõ½ÅÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. °Ë»ç ¹æ¹ý, µðÁöÅÐ °á°ú °ü¸® ¹× ºÐ¼® µµ±¸ÀÇ ¹ßÀüÀº °í¿ëÁÖ°¡ ÁøÈ­ÇÏ´Â ±ÔÁ¤À» ÁؼöÇϸ鼭 ¼±º° °úÁ¤À» °£¼ÒÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû°ú AI ±â¹Ý ºÐ¼®¿¡ ±â¹ÝÇÑ ´ÙÁß ÆÐ³Î °Ë»ç ¹× ±¸°­¾×ü °Ë»ç¸¦ äÅÃÇÏ¿© º¸´Ù ±¤¹üÀ§ÇÑ ¹°ÁúÀÇ °ËÃâ°ú ÀáÀçÀû ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÇâÈÄ ¸î ³â µ¿¾È ÀÛ¾÷Àå ¾ÈÀü ÇÁ·Î±×·¥À» °­È­ÇÏ°í º¸´Ù È¿°úÀûÀÎ Àη °ü¸®¸¦ Áö¿øÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå : ¸ðµå ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå : ¾à¹° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå¿ë ¾à¹° °Ë»ç ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï ±¸µµ

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Market Size & Trends:

The U.S. employer and workplace drug testing market size was estimated at USD 2.57 billion in 2024 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The market is primarily driven by stringent workplace safety regulations, growing awareness of substance abuse risks, and the increasing adoption of preventive screening measures across various industries. Drug testing programs are widely implemented to detect the presence of illicit substances and misuse of prescription medications, while comprehensive screening protocols support compliance with federal and state requirements, promote productivity, and reduce workplace incidents.

The demand for pre-employment and random workplace testing is growing, supported by improvements in rapid testing kits, lab-based tests, and oral fluid testing methods. Digital result systems and automated reporting have made the process faster and more accurate, helping employers make quick hiring decisions and monitor staff more effectively. Changing cannabis laws in several states are also leading companies to adjust their testing policies to meet both compliance needs and evolving legal standards.

A national survey by American Addiction Centers in 2024 found that 15.3% of U.S. workers had worked under the influence of alcohol, while 2.9% admitted to being under the influence of illegal drugs. This shows the ongoing challenges faced by employers and highlights the need for strong drug testing policies to protect workplace safety and productivity.

The rising number of employees with substance use disorders (SUD) further increases the importance of workplace testing. Substance abuse can lead to lower productivity, more absenteeism, and higher rates of illness. It also harms employee morale and raises the risk of workplace accidents and injuries, which together cost U.S. businesses billions of dollars each year. These factors are expected to keep driving the demand for employer and workplace drug testing services across the country.

Overall, the U.S. employer and workplace drug testing market is experiencing steady innovation aimed at improving speed, accuracy, and ease of use. Advancements in testing methods, digital result management, and analytical tools are helping employers streamline screening processes while ensuring compliance with evolving regulations. The adoption of multi-panel and oral fluid testing, supported by cloud-based platforms and AI-driven analytics, is making it easier to detect a broader range of substances and identify potential issues early. These innovations are expected to strengthen workplace safety programs and support more effective workforce management in the years ahead.

U.S. Employer And Workplace Drug Testing Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. employer and workplace drug testing market on type, product, mode, drug and end-use:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope

Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â